Acquired Blindness Clinical Trial
Official title:
VISIODOL: Validation of the VISIODOL® Scale for Screening of Pain in People With Visual Impairment
The aim of this study is to validate the VISIODOL® scale for screening of pain in people with visual impairment.
The VISIODOL® monocentric study conducted at Clermont-Ferrand University Hospital is a cross-disciplinary diagnostic tool validation performed in patients with acquired or congenital visual impairment and healthy sighted volunteers. Different evaluations by thermal (Pathway Médoc®) and mechanical (electronic Von Frey®) tests will allow to compare the new VISIODOL® scale with the numerical scale, which is a commonly used tool. The ergonomic quality, the satisfaction of use and the quality of life, stress, anxiety and catastrophism of the patients will also be studied. ;